1558. Associations between gender identity and solicited adverse events after passive infusion of VRC01 or placebo in HVTN 704/HPTN 085

BACKGROUND: Gender minority individuals are understudied in clinical trials. Realizing the potential of HIV prevention options requires understanding product tolerability across diverse groups vulnerable to HIV acquisition. Within HVTN 704/HPTN 085, a phase 2b trial of the broadly neutralizing antib...

Descripción completa

Detalles Bibliográficos
Autores principales: Theodore, Deborah, Neradilek, Moni, Gillespie, Kevin, Edupuganti, Srilatha, Hinojosa, Juan Carlos, Lama, Javier R, De La Grecca, Robert, Davis, Annet, Mangini, Daniel J, Andrew, Philip, Marovich, Mary, Zwerski, Sheryl, Castor, Delivette, Roxby, Alison C, Cohen, Myron, Corey, Lawrence, Huang, Yunda, Karuna, Shelly, Sobieszczyk, Magdalena E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677518/
http://dx.doi.org/10.1093/ofid/ofad500.1393

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677518/
http://dx.doi.org/10.1093/ofid/ofad500.1393

Ejemplares similares